Turning Point Therapeutics, Inc. Lock-Up AgreementGlaxosmithkline PLC • May 26th, 2020 • Pharmaceutical preparations
WAIVER OF REGISTRATION RIGHTS AND NOTICEGlaxosmithkline PLC • May 26th, 2020 • Pharmaceutical preparations
This Waiver of Registration Rights and Notice (this “Waiver”), dated as of May 15, 2020, is entered into by and among Turning Point Therapeutics, Inc. (the “Company”) and the undersigned stockholders of the Company.
